Related references
Note: Only part of the references are listed.The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients
Charles de Marcellus et al.
JOURNAL OF NEURO-ONCOLOGY (2022)
VEGF levels in patients with glioma: a systematic review and meta-analysis
Homa Seyedmirzaei et al.
REVIEWS IN THE NEUROSCIENCES (2021)
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
Scott Ryall et al.
CANCER CELL (2020)
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group
Jason Fangusaro et al.
LANCET ONCOLOGY (2020)
Efficacy and safety of bevacizumab in progressive pediatric low-grade glioma: a systematic review and meta-analysis of outcome rates
Victor M. Lu et al.
NEURO-ONCOLOGY PRACTICE (2020)
Management of pediatric low-grade glioma
Peter de Blank et al.
CURRENT OPINION IN PEDIATRICS (2019)
Current treatment of optic nerve gliomas
Marybeth K. Farazdaghi et al.
CURRENT OPINION IN OPHTHALMOLOGY (2019)
Bevacizumab in treating the cystic components of pediatric low-grade gliomas: A report of four patients
Erica Levenbaum et al.
PEDIATRIC BLOOD & CANCER (2019)
Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma
Nataliya Zhukova et al.
CANCER MEDICINE (2019)
Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort
Kevin Falzon et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2018)
Anti-VEGF treatment improves neurological function in tumors of the nervous system
Na Zhang et al.
EXPERIMENTAL NEUROLOGY (2018)
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report
Astrid K. Gnekow et al.
EUROPEAN JOURNAL OF CANCER (2017)
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
Anuradha Banerjee et al.
NEURO-ONCOLOGY (2017)
Clinical Presentation and Outcome of Patients With Optic Pathway Glioma
Viviane Robert-Boire et al.
PEDIATRIC NEUROLOGY (2017)
Phase II Weekly Vinblastine for Chemotherapy-Naive Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study
Alvaro Lassaletta et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1
Michael J. Wan et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab-irinotecan in children with low-grade glioma?
Marie Amelie Heng et al.
CANCER MEDICINE (2016)
Confirmation of Bevacizumab Activity, and Maintenance of Efficacy in Retreatment After Subsequent Relapse, in Pediatric Low-grade Glioma
Manas Kalra et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2015)
Efficacy of bevacizumab plus irinotecan in children with recurrent Low-grade gliomas-a Pediatric Brain Tumor Consortium study
Sridharan Gururangan et al.
NEURO-ONCOLOGY (2014)
Marked Recovery of Vision in Children With Optic Pathway Gliomas Treated With Bevacizumab
Robert A. Avery et al.
JAMA OPHTHALMOLOGY (2014)
Radiation, Atherosclerotic Risk Factors, and Stroke Risk in Survivors of Pediatric Cancer: A Report From the Childhood Cancer Survivor Study
Sabine Mueller et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method
David A. Walker et al.
NEURO-ONCOLOGY (2013)
Functional outcome measures for NF1-associated optic pathway glioma clinical trials
Michael J. Fisher et al.
NEUROLOGY (2013)
Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas
Eugene I. Hwang et al.
PEDIATRIC BLOOD & CANCER (2013)
Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
Joann L. Ater et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Experience with irinotecan for the treatment of malignant glioma
James J. Vredenburgh et al.
NEURO-ONCOLOGY (2009)
Objective Response of Multiply Recurrent Low-Grade Gliomas to Bevacizumab and Irinotecan
Roger J. Packer et al.
PEDIATRIC BLOOD & CANCER (2009)
Share Paper
